Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION
- DOI
- 10.1038/s41416-024-02615-9
- Published
- 2024-04-04
- Container
- British Journal of Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-024-02615-9,
title = {Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION},
author = {Terufumi Kato and James Chih-Hsin Yang and Myung-Ju Ahn and Hiroshi Sakai and Masahiro Morise and Yuh-Min Chen and Ji-Youn Han and Jin-Ji Yang and Jun Zhao and Te-Chun Hsia and Karin Berghoff and Rolf Bruns and Helene Vioix and Simone Lang and Andreas Johne and Xiuning Le and Paul K. Paik},
year = {2024},
journal = {British Journal of Cancer},
doi = {10.1038/s41416-024-02615-9},
url = {https://doi.org/10.1038/s41416-024-02615-9}
}RIS
TY - JOUR TI - Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION AU - Terufumi Kato AU - James Chih-Hsin Yang AU - Myung-Ju Ahn AU - Hiroshi Sakai AU - Masahiro Morise AU - Yuh-Min Chen AU - Ji-Youn Han AU - Jin-Ji Yang AU - Jun Zhao AU - Te-Chun Hsia AU - Karin Berghoff AU - Rolf Bruns AU - Helene Vioix AU - Simone Lang AU - Andreas Johne AU - Xiuning Le AU - Paul K. Paik PY - 2024 JO - British Journal of Cancer DO - 10.1038/s41416-024-02615-9 UR - https://doi.org/10.1038/s41416-024-02615-9 ER -
APA
Kato, T., Yang, J. C., Ahn, M., Sakai, H., Morise, M., Chen, Y., Han, J., Yang, J., Zhao, J., Hsia, T., Berghoff, K., Bruns, R., Vioix, H., Lang, S., Johne, A., Le, X., & Paik, P. K. (2024). Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION. British Journal of Cancer. https://doi.org/10.1038/s41416-024-02615-9
Source records
- crossref · retrieved 2026-09-26T20:49:09.452Z